Fuller & Thaler Asset Management
HAE icon

Fuller & Thaler Asset Management’s Haemonetics HAE Stock Holding History

Fuller & Thaler Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-49
Closed -$6K – 496
2019
Q4 		$6K Hold
49
– – ﹤0.01% 463
2019
Q3 		$6K Sell
49
-54
-52% -$6.85K ﹤0.01% 467
2019
Q2 		$12K Hold
103
– – ﹤0.01% 449
2019
Q1 		$9K Sell
103
-106
-51% -$9.64K ﹤0.01% 445
2018
Q4 		$21K Sell
209
-464,104
-100% -$48.8M ﹤0.01% 406
2018
Q3 		$53.2M Sell
464,313
-271,231
-37% -$28.1M 0.55% 66
2018
Q2 		$66M Sell
735,544
-14,085
-2% -$1.19M 0.71% 52
2018
Q1 		$54.8M Sell
749,629
-1,451
-0.2% -$99.6K 0.64% 60
2017
Q4 		$43.6M Sell
751,080
-1,078,193
-59% -$56.8M 0.52% 73
2017
Q3 		$82.1M Sell
1,829,273
-390,724
-18% -$16.2M 1% 33
2017
Q2 		$87.7M Buy
2,219,997
+10,547
+0.5% +$433K 1.15% 22
2017
Q1 		$89.6M Buy
2,209,450
+146,911
+7% +$5.74M 1.22% 21
2016
Q4 		$82.9M Sell
2,062,539
-55,341
-3% -$2.09M 1.25% 21
2016
Q3 		$76.7M Sell
2,117,880
-16,761
-0.8% -$575K 1.27% 20
2016
Q2 		$61.9M Buy
2,134,641
+311,959
+17% +$9.43M 1.06% 34
2016
Q1 		$63.8M Buy
1,822,682
+391,480
+27% +$12.6M 1.24% 25
2015
Q4 		$46.1M Buy
1,431,202
+339,084
+31% +$11M 0.99% 38
2015
Q3 		$35.3M Buy
1,092,118
+334,486
+44% +$12.6M 0.91% 37
2015
Q2 		$31.3M Buy
757,632
+146,975
+24% +$6.2M 0.89% 38
2015
Q1 		$27.4M Buy
610,657
+102,444
+20% +$4.28M 0.88% 38
2014
Q4 		$19M Buy
508,213
+73,334
+17% +$2.69M 0.69% 50
2014
Q3 		$15.2M Buy
434,879
+66,212
+18% +$2.36M 0.65% 45
2014
Q2 		$13M Buy
+368,667
New +$12.3M 0.55% 55

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fuller & Thaler Asset Management's HAE Position: Q1 2020 in Review

Fuller & Thaler Asset Management sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 49 shares — an estimated $6K sold.

Fuller & Thaler Asset Management first reported a position in HAE in Q2 2014 and held it in 23 quarters. The position peaked at $89.6M in Q1 2017. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • Fuller & Thaler Asset Management reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 49 Haemonetics shares in Q1 2020, an estimated $6K.
  • Fuller & Thaler Asset Management first reported a position in Haemonetics in Q2 2014 and held it in 23 quarters.
  • Fuller & Thaler Asset Management's Haemonetics position peaked at $89.6M in Q1 2017.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2020, filed 6 May 2020.